Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on PROTAC. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel thalidomide-based PROTACs for fibrosis and cancer. Efficient solid-phase synthesis ensures high purity and scalable supply chain solutions.
Patent CN109485695A details high-yield PROTAC synthesis. Enables cost reduction in anti-tumor drug manufacturing with scalable processes for reliable pharmaceutical intermediates supplier partnerships.
Patent CN114773316A details a scalable Grignard-based route for 2-(2,6-dioxo-piperidin-3-yl)-5-fluoro-isoindole-1,3-dione, offering high purity and cost-effective manufacturing for PROTAC intermediates.
Novel patent CN117924283A details high-yield spiro compound synthesis offering supply chain stability and cost efficiency for pharmaceutical intermediate manufacturing.